Hydroxychloroquine for COVID-19: Balancing contrasting claims. | Eur J Intern Med;82: 25-26, 2020 12. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Hydroxychloroquine for COVID-19: Balancing contrasting claims.

Horby, Peter W; Emberson, Jonathan R.

Horby PW; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom. Electronic address: peter.horby@ndm.ox.ac.uk.
Emberson JR; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, United Kingdom.

Eur J Intern Med ; 82: 25-26, 2020 12.

Article in English | MEDLINE | ID: covidwho-1059112

Subject(s)

COVID-19; Hydroxychloroquine; Humans; Italy; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hydroxychloroquine Limits: Humans Country/Region as subject: Europa Language: English Journal: Eur J Intern Med Journal subject: Internal Medicine Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hydroxychloroquine Limits: Humans Country/Region as subject: Europa Language: English Journal: Eur J Intern Med Journal subject: Internal Medicine Year: 2020 Document Type: Article